J
Josemir W. Sander
Researcher at UCL Institute of Neurology
Publications - 705
Citations - 44517
Josemir W. Sander is an academic researcher from UCL Institute of Neurology. The author has contributed to research in topics: Epilepsy & Population. The author has an hindex of 106, co-authored 680 publications receiving 39038 citations. Previous affiliations of Josemir W. Sander include University of Cincinnati & National Institute for Health Research.
Papers
More filters
Journal ArticleDOI
Eslicarbazepine acetate as a replacement for levetiracetam in people with epilepsy developing behavioral adverse events
Virupakshi Jalihal,Rohit Shankar,William Henley,Mary Parrett,Phil Tittensor,Brendan McLean,Ammad Ahmed,Josemir W. Sander +7 more
TL;DR: The findings suggest that ESL could be a treatment option in those who develop PBSEs with LEV and possibly other AEDs, and may be used as a possible alternative to LEV.
Journal ArticleDOI
Cancer mortality amongst people with epilepsy: A study of two cohorts with severe and presumed milder epilepsy
TL;DR: The modest excess of all cancer deaths and large excesses of deaths due to cancers at certain sites in the SEC and the lack thereof in the MEC suggests dissimilarity in the risk factor profile of the two populations.
Journal ArticleDOI
The intriguing relationship between epilepsy and type 1 diabetes mellitus
TL;DR: Four hypotheses are presented to explain the particular relationship between type 1 diabetes and epilepsy: metabolic abnormalities, cerebrovascular disease, genetic factors and autoimmune-related factors, and some of these have more merit than others.
Journal ArticleDOI
Seizures as a clinical manifestation in somatic autoimmune disorders
TL;DR: The risk of epileptic seizures seems increased in several systemic autoimmune disorders including systemic lupus erythematosus, type 1 diabetes mellitus, myasthenia gravis, celiac disease, rheumatoid arthritis, Hashimoto's encephalopathy, psoriasis, multiple sclerosis, neuromyelitis optica and bullous pemphigoid.
Journal ArticleDOI
Effect of oral contraceptives on lamotrigine levels depends on comedication.
TL;DR: To evaluate prospectively the influence of cyclic oral contraceptive use on lamotrigine (LTG) serum levels when used in combination therapy, a database of serum levels for cyclic and non-cyclic contraceptives is analyzed.